Ventricular Tachycardia Ablation in Structural Heart Disease With LVEF > 35%: Clinical Outcomes and Recurrence Patterns
This analysis focuses on VT recurrence after ablation in patients presenting with sustained VT and LVEF within a secondary‐prevention population.